date:Dec 04, 2019
first market in continental Europe represents a major milestone in BASFs efforts to offer a solution for the dietary management of NAFLD, notes Goh.
According to the company, 25 percent of people in Switzerland are living with NAFLD and Hepacor can contribute to their liver health by raising the levels of EPA and DHA needed for managing the disease.
The solution is manufactured in Norway using a patented purification technology to reduce persistent organic pollutants and other substances like